Guo-Lin Wang
Overview
Explore the profile of Guo-Lin Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu L, Ji P, Ren X, Wang Y, Lv C, Geng M, et al.
Lancet Reg Health West Pac
. 2025 Jan;
54:101261.
PMID: 39759426
Background: Co-existence of efficient transportation networks and geographic imbalance of medical resources greatly facilitated inter-city migration of patients of infectious diseases in China. Methods: To characterize the migration patterns of...
2.
Zhao X, Zhang S, Wei W, Xu Q, Lv C, Wang G, et al.
STAR Protoc
. 2024 Dec;
5(4):103497.
PMID: 39673704
T cell responses play an important role in viral clearance and prevention of infection. Here, we present a protocol to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell...
3.
Tian Y, Wang T, Chen J, Xu Q, Wang G, Jiang B, et al.
Heliyon
. 2024 Nov;
10(21):e39852.
PMID: 39553597
Objectives: The epidemical and clinical features of distinct hantavirus infections exhibit heterogeneity. However, the evolving epidemics and distinct determines of the two hantavirus infections remain uncertain. Methods: Data on hemorrhagic...
4.
Zhao X, Li X, Zhang S, Chen J, Zhao W, Wu N, et al.
Front Immunol
. 2024 Oct;
15:1477721.
PMID: 39434881
Introduction: With the continued prevalence of COVID-19, repeated infection caused by SARS-CoV-2 has become common. However, studies on immune persistence post Omicron XBB reinfection are limited. Methods: We prospectively studied...
5.
Zhao X, Li M, Zhang S, Li K, Wei W, Chen J, et al.
Heliyon
. 2024 Oct;
10(19):e38382.
PMID: 39398026
A great number of COVID-19 patients was caused by Omicron BA.5 subvariant between December 2022 and January 2023 after the end of the zero-COVID-19 policy in China. In this study,...
6.
Zhao X, Liu X, Gu H, Liu T, Li D, Zhang S, et al.
J Med Virol
. 2024 Aug;
96(8):e29873.
PMID: 39165041
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants raises concerns regarding the effectiveness of immunity acquired from previous Omicron subvariants breakthrough infections (BTIs) or reinfections (RIs)...
7.
Zhao X, Ji B, Shang C, Li D, Zhang S, Gu H, et al.
iScience
. 2024 Jul;
27(7):110283.
PMID: 39040063
The emergence of novel Omicron subvariants has raised concerns regarding the efficacy of immunity induced by prior Omicron subvariants breakthrough infection (BTI) or reinfection against current circulating Omicron subvariants. Here,...
8.
Zhao X, Liu X, Liang Y, Zhang S, Liu T, Li L, et al.
J Med Virol
. 2024 May;
96(5):e29640.
PMID: 38699969
After the termination of zero-COVID-19 policy, the populace in China has experienced both Omicron BA.5 and XBB waves. Considering the poor antibody responses and severe outcomes observed among the elderly...
9.
Tang T, Zhu Y, Zhang Y, Chen J, Tian J, Xu Q, et al.
Lancet Microbe
. 2024 Mar;
5(5):e442-e451.
PMID: 38467129
Background: The recent discovery of emerging relapsing fever group Borrelia (RFGB) species, such as Borrelia miyamotoi, poses a growing threat to public health. However, the global distribution and associated risk...
10.
Tian S, Liu T, Zhao X, Liu X, Li X, Du K, et al.
J Infect
. 2023 Oct;
87(6):598-601.
PMID: 37802470
No abstract available.